Samsung BioLogics and Biogen: Who Had Control?
The controversy surrounding Samsung Biologics Co., Ltd (207940 KS) 's booking of a fair value gain in 2015 relates to their claim of a "loss of...
473 Views
Samsung Biologics' Accounting Violation's Impact on Samsung C&T and Rest of the Korean Pharmas
On May 1st, 2018, Korea's Financial Supervisory Service (FSS) announced that Samsung Biologics Co., Ltd (207940 KS) violated accounting rules after...
309 Views
Samsung SDS = Spearheading the Blockchain Revolution + Alpha From Samsung Restructuring
In this report, we provide the major investment merits of Samsung SDS Co Ltd (018260 KS). We have a positive view of Samsung SDS and we are...
331 Views
The Controversy Surrounding Kim Ki-Sik (Head of FSS) & The Restructuring of the Samsung Group
A most important component of the restructuring of the Samsung Group is what to do with Samsung Life Insurance Co., Ltd (032830 KS)'s stakes in...
359 Views
The Week That Was In North Asia@Smartkarma: SK Lubricants, Celltrion, Renesas and Coincheck
KoreaDouglas Kim, Sanghyun Park and Sumeet Singh covered the Samsung C&T Corp (028260 KS) offering and SK Lubricants Co Ltd (0179791D KS) IPO,...
315 Views